Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy

Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy Publisher Pubmed

Balagholi S³ ; Dabbaghi R⁴ ; Eshghi P^{2, 3} ; Mousavi SA¹ ; Heshmati F⁵ ; Mohammadi S^{1, 3}

Source: Transfusion and Apheresis Science Published:2020

Abstract

Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma from other blood components and is considered as an adjunctive treatment strategy to the discarded abnormal agent in the management of respiratory viral pandemics. This article reviews the mechanisms of immunopathogenesis and coagulopathy induced by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 patients. © 2020

Related Docs

View other Related Docs

1. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)

2. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)

3. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (3)

Shekoufeh Nikfar (1)

Style	Citing Format
MLA	Balagholi S, et al.. "Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy." Transfusion and Apheresis Science, vol. 59, no. 6, 2020, pp. -.
APA	Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S (2020). Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy. Transfusion and Apheresis Science, 59(6), -.
Chicago	Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S. "Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy." Transfusion and Apheresis Science 59, no. 6 (2020): -.
Harvard	Balagholi S et al. (2020) 'Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy', Transfusion and Apheresis Science, 59(6), pp. -.
Vancouver	Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S. Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy. Transfusion and Apheresis Science. 2020;59(6):-.
BibTex	@article{ author = {Balagholi S and Dabbaghi R and Eshghi P and Mousavi SA and Heshmati F and Mohammadi S}, title = {Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy}, journal = {Transfusion and Apheresis Science}, volume = {59}, number = {6}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Balagholi S AU - Dabbaghi R AU - Eshghi P AU - Mousavi SA AU - Heshmati F AU - Mohammadi S TI - Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy JO - Transfusion and Apheresis Science VL - 59 IS - 6 SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Abstract